Contact
searchSearch
HMP Global

News

Research Highlights
BTK Inhibition With Rilzabrutinib Improves Symptoms in Uncontrolled Asthma
05/06/2026
Jessica Garlewicz
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's...
05/06/2026
Allergy & Immunology
Research Review
Remibrutinib Shows Promise in IgE-Mediated Peanut Allergy
04/23/2026
Riya Gandhi, MA
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued...
04/23/2026
Allergy & Immunology
News
Education Improves Shared Decision-Making in Food Allergy Care
04/23/2026
Riya Gandhi, MA
Shared decision making improves when patients receive education about approved therapies for food allergy treatment.
Shared decision making improves when patients receive education about approved therapies for food allergy treatment.
Shared decision making improves...
04/23/2026
Allergy & Immunology
AD
News
Upadacitinib 30 mg Emerges as Most Effective Oral JAK Inhibitor for Moderate-to-Severe Atopic Dermatitis in Bayesian Meta-Analysis
03/31/2026
Riya Gandhi, MA
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9 randomized trials position upadacitinib at the top for skin clearance and itch reduction.
Comparative data across 9...
03/31/2026
The Dermatologist
Research Review
Higher Phytochemical Intake Linked to Improved Pediatric Asthma Outcomes
03/18/2026
Rebecca Mashaw
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with...
03/18/2026
Allergy & Immunology
Research Review
Elevated Comorbidity Burden and Surgical Interventions in Patients With HAE-C1INH
03/18/2026
Jessica Garlewicz
Results of an analysis highlight the importance of integrating multisystem evaluation into the long-term care of HAE-C1INH patients, and stress the need for early and accurate diagnosis to prevent mismanagement and unnecessary procedures.
Results of an analysis highlight the importance of integrating multisystem evaluation into the long-term care of HAE-C1INH patients, and stress the need for early and accurate diagnosis to prevent mismanagement and unnecessary procedures.
Results of an analysis highlight...
03/18/2026
Allergy & Immunology
Research Review
Injectable On-Demand HAE Treatments Undermine Quality of Life, Study Finds
03/18/2026
Rebecca Mashaw
All participants reported at least one negative impact on HRQoL due to injectable on-demand treatment.
All participants reported at least one negative impact on HRQoL due to injectable on-demand treatment.
All participants reported at...
03/18/2026
Allergy & Immunology
Research Review
Oral Therapies Expand Options for Personalized Management of Hereditary Angioedema
03/18/2026
Jessica Garlewicz
This analysis highlights the emergence of oral agents as a practical alternative to parenteral therapies for both prophylaxis and acute attack management
This analysis highlights the emergence of oral agents as a practical alternative to parenteral therapies for both prophylaxis and acute attack management
This analysis highlights the...
03/18/2026
Allergy & Immunology
Research Highlights
Global Physician Survey Identifies Persistent Gaps in Achieving Treatment Goals for Hereditary Angioedema
03/18/2026
Jessica Garlewicz
The results of a physician survey highlight ongoing barriers to implementing consensus recommendations and underscore the need for broader education and improved access to therapy for HAE.
The results of a physician survey highlight ongoing barriers to implementing consensus recommendations and underscore the need for broader education and improved access to therapy for HAE.
The results of a physician...
03/18/2026
Allergy & Immunology
Research Summary
Acute Urticaria Incidence Declined During COVID-19
03/18/2026
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
03/18/2026
Allergy & Immunology

In the News

Research Highlights
BTK Inhibition With Rilzabrutinib Improves Symptoms in Uncontrolled Asthma
05/06/2026
Jessica Garlewicz
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's...
05/06/2026
Allergy & Immunology
Research Review
Remibrutinib Shows Promise in IgE-Mediated Peanut Allergy
04/23/2026
Riya Gandhi, MA
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued development of remibrutinib as a potential oral therapeutic option for food allergy.
These findings support continued...
04/23/2026
Allergy & Immunology
Research Review
Higher Phytochemical Intake Linked to Improved Pediatric Asthma Outcomes
03/18/2026
Rebecca Mashaw
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with...
03/18/2026
Allergy & Immunology
Research Summary
Acute Urticaria Incidence Declined During COVID-19
03/18/2026
Jessica Garlewicz
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis underscore the potential role of common viral infections as a trigger for AU and offer insight into changing disease patterns during the COVID-19 pandemic.
The findings of an analysis...
03/18/2026
Allergy & Immunology
Emerging Therapies
Advances in HAE Therapeutics Highlight Path Toward Personalized, Patient-Centered Care
03/02/2026
Jessica Garlewicz
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management will likely focus on tailoring regimens to patient-specific needs, attack phenotypes, and treatment goals.
The future of HAE management...
03/02/2026
Allergy & Immunology
FDA Alert
FDA Approves Twice-Yearly Biologic for Severe Eosinophilic Asthma
02/18/2026
Jessica Garlewicz
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first...
02/18/2026
Allergy & Immunology
Research Review
MDD in Asthma Patients Associated With Worse Outcomes in Older Adults
01/29/2026
Rebecca Mashaw
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by highlights how psychological health influences asthma control and healthcare utilization, underscoring a need for integrated care in older populations.
A recent cohort study by...
01/29/2026
Allergy & Immunology
Research Summary
Barriers to Normalization Persist for U.S. Patients With Hereditary Angioedema
01/18/2026
Rebecca Mashaw
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight persistent disease burden, frequent attacks, and widespread concern about lifelong medication use among patients being treated for hereditary angioedema.
New survey data highlight...
01/18/2026
Allergy & Immunology
Comorbidities
Oscillometry-Based Markers Reveal Airway Dynamics in Asthma–OSA Overlap
12/06/2025
Jessica Garlewicz
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic interactions remain complex, oscillometric patterns provided insight into changes in respiratory rhythm and resistance related to nocturnal airway collapse and remodeling.
While the exact mechanistic...
12/06/2025
Allergy & Immunology
Morbidity & Mortality
Mortality From Coexisting Asthma and Cardiovascular Disease Rising
12/06/2025
Jessica Garlewicz
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant disparities in mortality across demographic groups.
This analysis found significant...
12/06/2025
Allergy & Immunology

Popular Articles

Research Review
Outpatient Study Highlights Effectiveness of Penicillin Allergy Delabeling via Oral Challenge
11/17/2025
Jessica Garlewicz
A retrospective chart review conducted at an outpatient allergy clinic found that oral drug challenges are safe and highly effective for penicillin allergy delabeling.
A retrospective chart review conducted at an outpatient allergy clinic found that oral drug challenges are safe and highly effective for penicillin allergy delabeling.
A retrospective chart review...
11/17/2025
Allergy & Immunology
Quiz
Therapeutic Innovations in HAE
01/11/2026
Do you know about the most recent advances in therapies for hereditary angioedema? Take our quiz to test your knowledge!
Do you know about the most recent advances in therapies for hereditary angioedema? Take our quiz to test your knowledge!
Do you know about the most...
01/11/2026
Allergy & Immunology
Research Highlights
Elevated Comorbidity Burden and Surgical Interventions in Patients With HAE-C1INH
12/06/2025
Jessica Garlewicz
Study findings underscore the need for heightened clinical surveillance and early recognition to avoid unnecessary procedures and improve long-term patient outcomes.
Study findings underscore the need for heightened clinical surveillance and early recognition to avoid unnecessary procedures and improve long-term patient outcomes.
Study findings underscore the...
12/06/2025
Allergy & Immunology
Research Highlights
OTC Budesonide-Formoterol Would Be Cost-Effective Alternative to Inhaled Epinephrine for Mild Asthma
02/17/2026
Jessica Garlewicz
The findings address a gap in OTC options for asthma management, where inhaled epinephrine remains the only nonprescription therapy in the United States.
The findings address a gap in OTC options for asthma management, where inhaled epinephrine remains the only nonprescription therapy in the United States.
The findings address a gap in...
02/17/2026
Allergy & Immunology
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use